01—Abstract
Summary
Summary of the 8-K/A filed September 18, 2025. Cited figures are marked; the original filing is the authoritative source.
This 8-K/A filing from Synopsys Inc. (SNPS) is an amendment to a previous report detailing changes to its Board of Directors and committees.
The primary update is the appointment of Mr. Vijayaraghavan to the Corporate Governance and Nominating Committee, effective September 17, 2025. This follows his initial appointment to the Board of Directors on July 17, 2025.
For investors, this indicates continued board refreshment and focus on governance matters. The committee role suggests Mr. Vijayaraghavan will be involved in the oversight of board composition, director nominations, and corporate governance policies, which are crucial for long-term company health and shareholder value.
02—Key points
Key Highlights
- Amendment to a prior 8-K filing regarding board changes.
- Mr. Vijayaraghavan appointed to the Corporate Governance and Nominating Committee on September 17, 2025.
- Mr. Vijayaraghavan was initially appointed to the Board of Directors on July 17, 2025.
- This filing focuses on committee appointments, signaling ongoing board structure adjustments.
- The Corporate Governance and Nominating Committee plays a key role in director selection and governance oversight.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K/A filing?
This filing is an amendment to a previous 8-K report. Its main purpose is to inform investors about the appointment of Mr. Vijayaraghavan to the Corporate Governance and Nominating Committee of Synopsys Inc.'s Board of Directors.
When did Mr. Vijayaraghavan join the Board and the committee?
Mr. Vijayaraghavan was first appointed to the Board of Directors on July 17, 2025. His appointment to the Corporate Governance and Nominating Committee was effective on September 17, 2025.
Why is the appointment to the Corporate Governance and Nominating Committee important for investors?
This committee is responsible for crucial aspects of corporate governance, including board composition, director nominations, and policies. Mr. Vijayaraghavan's role on this committee suggests active oversight of these areas, which can impact long-term shareholder value and company accountability.
04—Continue